Literature DB >> 12730806

Hepatic-artery aneurysm in adult liver transplantation.

Surasak Leelaudomlipi1, Simon R Bramhall, Bridget K Gunson, Daniel Candinas, John A C Buckels, Paul McMaster, Darius F Mirza, A David Mayer.   

Abstract

Hepatic artery aneurysm (HAA) is a rare vascular complication, but has a high mortality rate in liver transplant recipients. This study reports the precipitating factors, clinical manifestation, pre-operative diagnosis, related micro-organism, management, and outcome, in a series of HAAs that developed after adult orthotopic liver transplantation (OLT). Data on the primary disease as well as on the above were obtained from a prospective database, and all case records were reviewed. There were eight (0.5%) HAAs in 1,575 adult cadaveric OLTs between 1982 and March 2001. All were pseudo-aneurysms around the native hepatic-artery (HA) anastomosis, and all occurred in whole-organ OLTs. There were three types of clinical presentations: sudden hypotension (n=4), gastrointestinal (GI) bleeding (n=2), and abnormal liver-function tests (LFTs) (n=2). The majority (n=7) presented within the first 2 months (median: 27.5 days, range: 12-760 days) following OLT. A pre-operative diagnosis of HAA was not determined in five cases. The sensitivity of abdominal ultrasound scan (USS), computed tomography (CT) scan and angiography for detection of HAAs was 3 of 5, 1 of 2 and 3 of 4, respectively. Micro-organisms could be identified in six patients (bacteria n=4 and fungi n=3). All patients underwent urgent operations (excision of HAA in six and ligation in two cases). Immediate reconstruction of the HA was carried out, two different methods being used: repair of native arteries (n=2) and arterial conduit (interposition n=3 and aortic conduit n=2). Two patients died peri-operatively, two died within 2 months, and the remaining four patients are alive at between 8.6 and 12.8 years after repair. HAA following OLT is unpredictable in its presentation, and the sensitivity of clinical and radiological detection is low. A high index of suspicion is required, and urgent surgery with immediate re-vascularisation and use of appropriate antibiotic/anti-fungal agents is recommended.

Entities:  

Mesh:

Year:  2003        PMID: 12730806     DOI: 10.1007/s00147-003-0551-0

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

Review 1.  Vascular complications after adult living donor liver transplantation: Evaluation with ultrasonography.

Authors:  Lin Ma; Qiang Lu; Yan Luo
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 2.  Vascular complications following liver transplantation: A literature review of advances in 2015.

Authors:  Tullio Piardi; Martin Lhuaire; Onorina Bruno; Riccardo Memeo; Patrick Pessaux; Reza Kianmanesh; Daniele Sommacale
Journal:  World J Hepatol       Date:  2016-01-08

3.  Post-transplant hepatic complications: Imaging findings.

Authors:  F M Drudi; E Pagliara; V Cantisani; F Arduini; U D'Ambrosio; G Alfano
Journal:  J Ultrasound       Date:  2007-04-16

4.  Massive duodenal ulcer bleeding due to the ruptured hepatic artery pseudoaneurysm after living donor liver transplantation.

Authors:  Masashi Kadohisa; Yukihiro Inomata; Masataka Sakisaka; Yasuhiko Sugawara; Taizo Hibi
Journal:  Surg Case Rep       Date:  2022-10-18

5.  Visceral artery aneurysms in liver transplant candidates and in patients after liver transplantation.

Authors:  Umberto Maggi; Daniele Dondossola; Dario Consonni; Stefano Gatti; Rossella Arnoldi; Manuela Bossi; Giorgio Rossi
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

6.  Case report of hepatic artery dissection secondary to hepatic artery pseudoaneurysm after living donor liver transplantation.

Authors:  Lin Ma; Kefei Chen; Qiang Lu; Wenwu Ling; Yan Luo
Journal:  BMC Gastroenterol       Date:  2016-04-01       Impact factor: 3.067

7.  Hepatic Artery Pseudoaneurysm in the Liver Transplant Recipient: A Case Series.

Authors:  David P St Michel; Naeem Goussous; Nathalie L Orr; Rolf N Barth; Stephen H Gray; John C LaMattina; David A Bruno
Journal:  Case Rep Transplant       Date:  2019-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.